Sitagliptin Tablet
Product Images NDC 70771-1792

6 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 70771-1792). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 04)

Image (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 04)
Chemical structure of sitagliptin, showing its molecular framework with fluorinated phenyl ring, amino group, and trifluoromethyl-substituted triazole ring.*
FDA Label Image

Image (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 05)

Image (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 05)
A line graph depicting the LS mean change from baseline over 24 weeks for different treatment groups: Placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, and two combo treatments of Sitagliptin 50 mg twice daily with Metformin 500 mg or 1000 mg twice daily. The x-axis represents time in weeks, and the y-axis shows the change from baseline.*
FDA Label Image

Image (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 06)

Image (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 06)
A line graph showing LS mean change from baseline over 52 weeks. The x-axis represents time in weeks, starting at 0 through 52, and the y-axis shows the LS mean change from baseline, ranging from 0.0 to -1.5. Two lines with different markers plot data points that decrease sharply by week 6, then plateau and slightly increase near week 52.*
FDA Label Image

25 mg Label (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 01)

25 mg Label (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 01)
Sitagliptin Tablets 25 mg oral tablets label from Zydus Lifesciences Limited. The label indicates a 90-tablet package with instructions to dispense a medication guide to patients. It includes storage instructions, dosage reference, child resistance notice, and manufacturer details in Ahmedabad, India. The label shows the National Drug Code (NDC) 70771-1790-9 and a barcode.*
FDA Label Image

50 mg Label (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 02)

50 mg Label (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 02)
Sitagliptin Tablets 50 mg film-coated oral tablets label by Zydus Lifesciences Limited. The package contains 90 tablets and is marked Rx only. The label includes dosage strength, storage instructions, child safety warning, and manufacturer details. A barcode and the National Drug Code (NDC 70771-1791-9) are also visible.*
FDA Label Image

100 mg Label (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 03)

100 mg Label (Fb6b8cba Effb 41c6 8384 3d05a5c9bd89 03)
Sitagliptin Tablets 100 mg film-coated tablet label by Zydus Lifesciences Limited. The label includes dosage strength, quantity of 90 tablets, and instructions to dispense the enclosed Medication Guide. It also shows storage instructions, child resistance warning, and manufacturer location in Ahmedabad, India. The design features white, green, and purple colors with barcode and NDC 70771-1792-9.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.